Mylan Launches Generic Version of Menopause Drug

Article

Mylan Inc. has announced the US launch of its estradiol transdermal system, the generic version of Novartis' Vivelle-DOT.

Mylan Inc. has announced the US launch of its estradiol transdermal system, the generic version of Novartis' Vivelle-DOT.

The announcement follows the FDA’s final approval of Mylan’s Abbreviated New Drug Application for the product, which is indicated for the treatment of moderate-to-severe vasomotor symptoms and symptoms of vulvar and vaginal atrophy due to menopause; hypoestrogenism due to hypogonadism, castration, or primary ovarian failure; and the prevention of postmenopausal osteoporosis.

"The approval of Mylan's estradiol transdermal system USP represents our seventh US transdermal product launch and strengthens the company's growing portfolio of women's health products,” said Mylan CEO Heather Bresch in a press release. “We look forward to continuing to meet patient needs in this space as we strive to provide the world's 7 billion people access to high quality medicines."

Mylan’s estradiol transdermal system will be available in twice-weekly strengths of 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day.

Related Videos
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Medical team -- Image credit: Flamingo Images | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.